C-terminus of heat shock protein 70-interacting protein-dependent GTP cyclohydrolase I degradation in lambs with increased pulmonary blood flow

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 1, 2011, Pages 163-171

  Sun, Xutong ^a   Fratz, Sohrab ^b   Sharma, Shruti ^a   Hou, Yali ^a   Rafikov, Ruslan ^a   Kumar, Sanjiv ^a   Rehmani, Imran ^a   Tian, Jing ^a   Smith, Anita ^a   Schreiber, Christian ^b   Reiser, Judith ^b   Naumann, Susanne ^b   Haag, Sebastian ^b   Hess, John ^b   Catravas, John D ^a   Patterson, Cam ^c   Fineman, Jeffery R ^d   Black, Stephen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hsp70; Hsp90; Mitochondrial dysfunction; Proteasome; Ubiquitination

Indexed keywords

ARGININE; BINDING PROTEIN; C TERMINUS OF HSP70 INTERACTING PROTEIN; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HEAT SHOCK PROTEIN 70; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; LAMB; LUNG BLOOD FLOW; NONHUMAN; PROTEIN INTERACTION; UBIQUITINATION;

ANILINE COMPOUNDS; ANIMALS; ANTHRACENES; BLOOD FLOW VELOCITY; DISEASE MODELS, ANIMAL; FEMALE; GTP CYCLOHYDROLASE; HEART DEFECTS, CONGENITAL; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; LUNG; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPANE; PROTEASOME ENDOPEPTIDASE COMPLEX; SHEEP;

OVIS ARIES;

EID: 80051573596     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0467OC     Document Type: Article

References (33)

1. Sud N, Wells SM, Sharma S, Wiseman DA, Wilham J, Black SM. Asymmetric dimethylarginine inhibits Hsp90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am J Physiol Cell Physiol 2008;294:C1407-C1418.
2. Mangoni AA. The emerging role of symmetric dimethylarginine in vascular disease. Adv Clin Chem 2009;48:73-94.
3. Boger RH. Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 2003;41:1467-1472. (Pubitemid 37493562)
4. Boger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 2004;134(Suppl 10):2842S-2847S, 2853S.
5. Arrigoni FI, Vallance P, Haworth SG, Leiper JM. Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation 2003;107:1195-1201. (Pubitemid 36297214)
6. Schmidt TS, Alp NJ. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 2007;113:47-63. (Pubitemid 47066025)
7. Auerbach G, Nar H. The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem 1997;378:185-192. (Pubitemid 27230601)
8. Swick L, Kapatos G. A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions. J Neurochem 2006;97:1447-1455. (Pubitemid 43725583)
9. Whitsett J, Picklo MJ Sr, Vasquez-Vivar J. 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 2007;27:2340-2347. (Pubitemid 350203948)
10. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, Fineman JR. In utero placement of aortopulmonary shunts: a model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 1995;92:1-8.
11. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002;106:987-992. (Pubitemid 34925335)
12. Kelly LK, Wedgwood S, Steinhorn RH, Black SM. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol 2004;286:L984-L991. (Pubitemid 38508809)
13. Kumar S, Sun X, Sharma S, Aggarwal S, Ravi K, Fineman JR, Black SM. GTP cyclohydrolase I expression is regulated by nitric oxide: role of cyclic AMP. Am J Physiol Lung Cell Mol Physiol 2009;297:L309-L317.
14. Wainwright MS, Arteaga E, Fink R, Ravi K, Chace DH, Black SM. Tetrahydrobiopterin and nitric oxide synthase dimer levels are not changed following hypoxia-ischemia in the newborn rat. Brain Res Dev Brain Res 2005;156:183-192. (Pubitemid 41132128)
15. Sud N, Sharma S, Wiseman DA, Harmon C, Kumar S, Venema RC, Fineman JR, Black SM. Nitric oxide and superoxide generation from endothelial NOS: modulation by Hsp90. Am J Physiol Lung Cell Mol Physiol 2007;293:L1444-L1453. (Pubitemid 350255027)
16. Daicho T, Yagi T, Abe Y, Ohara M, Marunouchi T, Takeo S, Tanonaka K. Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats. J Pharmacol Sci 2009;111:33-43.
17. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for C-Erbb2/Neu. Proc Natl Acad Sci USA 2002;99:12847-12852.
18. Dewey CF Jr, Bussolari SR, Gimbrone MA Jr, Davies PF. The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 1981;103:177-185.
19. Wedgwood S, Bekker JM, Black SM. Shear stress regulation of endothelial NOS in fetal pulmonary arterial endothelial cells involves PKC. Am J Physiol Lung Cell Mol Physiol 2001;281:L490-L498.
20. Sharma S, Sud N, Wiseman DA, Carter AL, Kumar S, Hou Y, Rau T, Wilham J, Harmon C, Oishi P, et al. Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008;294:L46-L56. (Pubitemid 351380317)
21. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the Hsp90/Hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003;228:111-133. (Pubitemid 36187918)
22. Bercovich B, Stancovski I, Mayer A, Blumenfeld N, Laszlo A, Schwartz AL, Ciechanover A. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem 1997;272:9002-9010. (Pubitemid 27154900)
23. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-479. (Pubitemid 28411135)
24. Sharma S, Grobe AC, Wiseman DA, Kumar S, Englaish M, Najwer I, Benavidez E, Oishi P, Azakie A, Fineman JR, et al. Lung antioxidant enzymes are regulated by development and increased pulmonary blood flow. Am J Physiol Lung Cell Mol Physiol 2007;293:L960-L971. (Pubitemid 47572244)
25. Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH. Proteasome-dependent degradation of guanosine 59-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 2007;116:944-953. (Pubitemid 47300919)
26. Jiang J, Cyr D, Babbitt RW, Sessa WC, Patterson C. Chaperonedependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. J Biol Chem 2003;278:49332-49341.
27. Xia T, Dimitropoulou C, Zeng J, Antonova GN, Snead C, Venema RC, Fulton D, Qian S, Patterson C, Papapetropoulos A, et al. Chaperone-dependent E3 ligase chip ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase. Am J Physiol Heart Circ Physiol 2007;293:H3080-H3087. (Pubitemid 350106533)
28. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, Sessa WC. Domain mapping studies reveal that the M domain of Hsp90 serves as a molecular scaffold to regulate AKT-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 2002;90:866-873. (Pubitemid 34633878)
29. Schulte TW, Akinaga S, Soga S, Sullivan W, Stensgard B, Toft D, Neckers LM. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaperones 1998;3:100-108. (Pubitemid 28327422)
30. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002;82:373-428. (Pubitemid 34654457)
31. Peng HM, Morishima Y, Jenkins GJ, Dunbar AY, Lau M, Patterson C, Pratt WB, Osawa Y. Ubiquitylation of neuronal nitric-oxide synthase by CHIP, a chaperone-dependent E3 ligase. J Biol Chem 2004;279:52970-52977. (Pubitemid 40051795)
32. Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in APOE-knockout mice. Arterioscler Thromb Vasc Biol 2004;24:445-450. (Pubitemid 38326136)
33. Crabtree MJ, Tatham AL, Hale AB, Alp NJ, Channon KM. Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric oxide synthase coupling: relative importance of the de novo biopterin synthesis vs. salvage pathways. J Biol Chem 2009;284:28128-28136.